Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhoon Yoo

Showing results (11-20 of 250) with videos related to

Pageof 25
Sort By:
Radiologic Clinics of North America|August 21, 2022
Update on Biliary Cancer ImagingDong Wook Kim, So Yeon Kim, Changhoon Yoo, et al.
British Journal of Cancer|May 13, 2023
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumoursHyung-Don Kim, Changhoon Yoo, Min-Hee Ryu, et al.
International Journal of Food Microbiology|May 16, 2020
Labchip-based diagnosis system for on-site application: Sensitive and easy-to-implement detection of single recoverable Cronobacter in infant formula without post-enrichment treatmentTae Jin Cho, Hye Won Kim, Changhoon Yoo, et al.
Investigational New Drugs|April 18, 2013
Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumorsChanghoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Anticancer Research|November 29, 2023
PARP Inhibitor Sensitizes <i>BRCA</i>-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 AxisChorong Kim, Danbee Kim, DA Sol Lee, et al.
Anticancer Research|July 5, 2022
The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1DA Sol Lee, Seonmin Lee, Chorong Kim, et al.
Cancer Research and Treatment|July 2, 2015
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal TumorsChanghoon Yoo, Min-Hee Ryu, Jungmin Jo, et al.
Annals of Hematology|October 22, 2009
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myelomaJeong Eun Kim, Changhoon Yoo, Dae Ho Lee, et al.
Anticancer Research|December 31, 2021
Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma CellsChorong Kim, Seonmin Lee, Danbee Kim, et al.
Journal of Korean Medical Science|August 21, 2013
Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patientsShinkyo Yoon, Min-Hee Ryu, Changhoon Yoo, et al.
Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Radiologic Clinics of North America|August 21, 2022
Update on Biliary Cancer ImagingDong Wook Kim, So Yeon Kim, Changhoon Yoo, et al.
British Journal of Cancer|May 13, 2023
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumoursHyung-Don Kim, Changhoon Yoo, Min-Hee Ryu, et al.
International Journal of Food Microbiology|May 16, 2020
Labchip-based diagnosis system for on-site application: Sensitive and easy-to-implement detection of single recoverable Cronobacter in infant formula without post-enrichment treatmentTae Jin Cho, Hye Won Kim, Changhoon Yoo, et al.
Investigational New Drugs|April 18, 2013
Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumorsChanghoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Anticancer Research|November 29, 2023
PARP Inhibitor Sensitizes <i>BRCA</i>-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 AxisChorong Kim, Danbee Kim, DA Sol Lee, et al.
Anticancer Research|July 5, 2022
The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1DA Sol Lee, Seonmin Lee, Chorong Kim, et al.
Cancer Research and Treatment|July 2, 2015
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal TumorsChanghoon Yoo, Min-Hee Ryu, Jungmin Jo, et al.
Annals of Hematology|October 22, 2009
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myelomaJeong Eun Kim, Changhoon Yoo, Dae Ho Lee, et al.
Anticancer Research|December 31, 2021
Blockade of GRP78 Translocation to the Cell Surface by HDAC6 Inhibition Suppresses Proliferation of Cholangiocarcinoma CellsChorong Kim, Seonmin Lee, Danbee Kim, et al.
Journal of Korean Medical Science|August 21, 2013
Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patientsShinkyo Yoon, Min-Hee Ryu, Changhoon Yoo, et al.
Pageof 25